Piotr Niezgoda - Concepedia

Author

Piotr Niezgoda

Nicolaus Copernicus University ORCID

Also Known As

Malwina Barańska, P Niezgoda, Piotr Niezgoda

Publications

559

Citations

H-Index

Concepts

All Affiliations

Nicolaus Copernicus University Imperial College London University of Hertfordshire Medical University of Warsaw Gdańsk Medical University

About

Piotr Niezgoda is an author at Nicolaus Copernicus University specializing in medicine, cardiovascular disease, and atherosclerosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	162
2	Public Health	2	2	42
3	Emergency Medicine	2	2	31
4	Graphic Design	1	1	28
5	Immunology	1	1	79

Piotr Niezgoda

Publications

258

Citations

H-Index

Page 1

	Year	Citations
PCSK9 Inhibition During the Inflammatory Stage of SARS-CoV-2 Infection Eliano Pio Navarese, Przemysław Podhajski, Paul A. Gurbel, Journal of the American College of Cardiology Pcsk9 InhibitionViral PathogenesisImmunologyAntiviral ResponseMedicine	2023	79
METoclopramide Administration as a Strategy to Overcome MORPHine-ticagrelOr Interaction in PatientS with Unstable Angina PectorIS—The METAMORPHOSIS Trial Joanna Sikora, Piotr Niezgoda, Malwina Barańska, Thrombosis and Haemostasis	2018	53
Determinants of high platelet reactivity in patients with acute coronary syndromes treated with ticagrelor Piotr Adamski, Katarzyna Buszko, Joanna Sikora, Scientific Reports	2019	31
Long-Term Outcomes Following Drug-Eluting Balloons Versus Thin-Strut Drug-Eluting Stents for Treatment of In-Stent Restenosis (DEB-Dragon-Registry) Wojciech Wańha, Jacek Bil, Rafał Januszek, Circulation Cardiovascular Interventions Percutaneous Coronary InterventionVisual LanguageEndovascular TechniqueCardiovascular DiseaseGraphic Design	2021	28
Metabolism of ticagrelor in patients with acute coronary syndromes Piotr Adamski, Katarzyna Buszko, Joanna Sikora, Scientific Reports Ticagrelor TransformationCardiovascular PharmacologyPharmacotherapyCoronary Artery DiseaseThrombosis	2018	24
Prolonged antithrombotic therapy in patients after acute coronary syndrome: A critical appraisal of current European Society of Cardiology guidelines Jacek Kubica, Piotr Adamski, Piotr Niezgoda, Cardiology Journal HypertensionCardiovascular DeathCardiovascular PharmacologyPharmacotherapyAcute Myocardial Infarction	2020	18
A new approach to ticagrelor-based de-escalation of antiplatelet therapy after acute coronary syndrome. A rationale for a randomized, double-blind, placebo-controlled, investigator-initiated, multicenter clinical study Jacek Kubica, Piotr Adamski, Piotr Niezgoda, Cardiology Journal Cardiovascular PharmacologyPharmacotherapyCoronary Artery DiseaseAcute Myocardial InfarctionThrombosis	2021	13
COVID-19 pandemic year in the cardiology department Piotr Lackowski, Maciej Piasecki, Michał Kasprzak, Medical Research Journal	2021	12

Page 1